Arrowstreet Capital, Limited Partnership Boston Scientific Corp Transaction History

Arrowstreet Capital, Limited Partnership

$121 Billion
Q3 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Boston Scientific Corp stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 5,105,038 shares of BSX stock, worth $456 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

5,105,038

Previous 4,814,472 6.04%

Holding current value

$456 Million

Previous $371 Million 15.38%

% of portfolio

0.35%

Previous 0.33%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $21.2 Million - $24.4 Million	290,566 Added 6.04%	5,105,038 $428 Million
Q2 2024 Aug 14, 2024	SELL	$67.33 - $77.71 $5.88 Million - $6.79 Million	-87,334 Reduced 1.78%	4,814,472 $371 Million
Q1 2024 May 15, 2024	SELL	$57.6 - $68.62 $66 Million - $78.6 Million	-1,146,008 Reduced 18.95%	4,901,806 $336 Million
Q4 2023 Feb 14, 2024	SELL	$48.64 - $57.81 $77.3 Million - $91.9 Million	-1,589,034 Reduced 20.81%	6,047,814 $350 Million
Q3 2023 Nov 14, 2023	SELL	$50.19 - $54.68 $63.1 Million - $68.8 Million	-1,258,037 Reduced 14.14%	7,636,848 $403 Million
Q2 2023 Aug 14, 2023	BUY	$49.72 - $54.64 $18 Million - $19.8 Million	362,495 Added 4.25%	8,894,885 $481 Million
Q1 2023 May 15, 2023	BUY	$45.09 - $50.03 $2.32 Million - $2.57 Million	51,412 Added 0.61%	8,532,390 $427 Million
Q4 2022 Feb 14, 2023	BUY	$39.56 - $47.22 $25.1 Million - $29.9 Million	633,546 Added 8.07%	8,480,978 $392 Million
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $11.3 Million - $33.8 Million	307,805 Added 4.08%	7,847,432 $304 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $74.3 Million - $99.3 Million	2,108,813 Added 38.83%	7,539,627 $281 Million
Q1 2022 May 13, 2022	BUY	$40.9 - $45.1 $88.3 Million - $97.3 Million	2,157,849 Added 65.93%	5,430,814 $241 Million
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $91 Million - $107 Million	2,391,242 Added 271.2%	3,272,965 $139 Million
Q3 2021 Nov 12, 2021	BUY	$41.23 - $45.88 $35.1 Million - $39.1 Million	851,823 Added 2848.91%	881,723 $38.3 Million
Q2 2021 Aug 13, 2021	BUY	$38.58 - $44.24 $1.15 Million - $1.32 Million	29,900 New	29,900 $1.28 Million
Q1 2021 May 14, 2021	SELL	$35.27 - $39.67 $8.57 Million - $9.64 Million	-242,898 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$33.15 - $41.97 $7.76 Million - $9.83 Million	234,198 Added 2691.93%	242,898 $8.73 Million
Q3 2020 Nov 12, 2020	SELL	$34.44 - $42.23 $2.56 Million - $3.14 Million	-74,324 Reduced 89.52%	8,700 $332,000
Q2 2020 Aug 12, 2020	SELL	$30.19 - $39.11 $58.3 Million - $75.5 Million	-1,930,502 Reduced 95.88%	83,024 $2.92 Million
Q1 2020 May 15, 2020	BUY	$25.83 - $45.71 $52 Million - $92 Million	2,013,526 New	2,013,526 $65.7 Million
Q2 2019 Aug 14, 2019	SELL	$34.91 - $42.98 $219,932 - $270,774	-6,300 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$32.91 - $40.75 $141,512 - $175,225	-4,300 Reduced 40.57%	6,300 $242,000
Q4 2018 Feb 14, 2019	BUY	$31.73 - $39.04 $336,338 - $413,824	10,600 New	10,600 $375,000
Q2 2018 Aug 14, 2018	SELL	$26.84 - $34.32 $23.6 Million - $30.1 Million	-878,175 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$25.2 - $28.54 $158 Million - $179 Million	-6,271,672 Reduced 87.72%	878,175 $24 Million
Q4 2017 Feb 09, 2018	BUY	$24.79 - $29.8 $140 Million - $168 Million	5,633,721 Added 371.59%	7,149,847 $177 Million
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $39.8 Million - $44.2 Million	1,516,126	1,516,126 $44.2 Million

Others Institutions Holding BSX

# of Institutions

1,541

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $128B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Boston Scientific Corp Transaction History